Canaccord


IMPINJ Inc (PI) Beats Estimates; Top Analyst Weighs In

IMPINJ Inc (NASDAQ:PI) shares climbed nearly 8% in Friday’s trading session, after the radio frequency identification technology maker blew away expectations for its first-quarter earnings, …

Canaccord Shares Two Cents on Nokia (ADR) (NOK) Technologies Division

Given the challenging macro likely to persist through 2018, Canaccord analyst Michael Walkley remains neutral on Nokia (ADR) (NYSE:NOK) shares, reiterating a Hold rating and …

Canaccord Boosts Price Target For Chipotle Mexican Grill, Inc. (CMG), But Sees 9% Downside

In a research report released Wednesday, Canaccord analyst Lynne Collier reiterated a Hold rating on shares of Chipotle Mexican Grill, Inc. (NYSE:CMG), while …

Endo International plc (ENDP) Long-Term Strategy Remains Unclear

Canaccord analyst Dewey Steadman is out with a research note on shares of Endo International plc (NASDAQ:ENDP), after the drug giant reported first quarter preliminary revenue …

Endo International plc – Ordinary Shares (ENDP): Opana ER Gets Thumbs Down from FDA Panel, Canaccord Sees Just a Modest Impact

This afternoon, a joint session of the FDA Drug Safety and Risk Management and the Anesthetic and Analgesic Drug Products Advisory Committees voted …

Aurinia Pharmaceuticals Inc (AUPH): Voclosporin’s Long-Term Phase 2 Data Points for Assessing the Probability of Phase 3 Success

This is an exciting time for Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) and its shareholders. The shares have gone up over 120% after the drug maker announced positive …

Top Analyst Boosts Price Target on Advanced Micro Devices, Inc. (AMD), Sees Risk/Reward Tilted Toward Upside

After hosting a series of focused investor meetings with Advanced Micro Devices, Inc. (NASDAQ:AMD) CEO Dr.

Top Analyst Cautious on Nokia Corp (ADR) in Short-Term

After hosting an investor meeting with CFO Kristian Pullola at Mobile World Congress, the largest global gathering for the mobile industry, top analyst …

Canaccord Chimes in on Synergy Pharmaceuticals Inc (SGYP) as It Prepares for Trulance Launch

Yesterday, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) reported fourth-quarter financial results and reiterated the launch of Trulance (plecanatide), Synergy’s recently-approved lead drug, for treatment of chronic …

Canaccord Applauds Aurinia Pharmaceuticals Inc (AUPH) As Shares Shatter Through the Roof at 66%

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is on fire today with shares zooming up 66% in pre-market trading after the biotech firm’s drug voclosporin scored …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts